(19)
(11) EP 1 572 643 A2

(12)

(88) Date of publication A3:
15.07.2004

(43) Date of publication:
14.09.2005 Bulletin 2005/37

(21) Application number: 03812471.5

(22) Date of filing: 26.11.2003
(51) International Patent Classification (IPC)7C07D 207/34, A61K 31/40
(86) International application number:
PCT/US2003/038090
(87) International publication number:
WO 2004/050618 (17.06.2004 Gazette 2004/25)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 28.11.2002 EP 02406037
20.02.2003 EP 03405110

(71) Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
49131 Petah Tiqva (IL)

(72) Inventors:
  • BLATTER, Fritz
    CH-4153 Reinach (CH)
  • SZELAGIEWICZ, Martin
    CH-4142 Münchenstein (CH)
  • VAN DER SCHAAF, Paul Adriaan
    CH-4123 Allschwill (CH)

(74) Representative: Gallagher, Kirk James et al
D Young & Co 120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

   


(54) CRYSTALLINE FORM F OF ATORVASTATIN HEMI-CALCIUM SALT